Bruno M. Duarte
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.
Journal: International journal of dermatology
Published: July 02, 2026
A 17-year-old boy with hemifacial flushing and anhidrosis.
Journal: JAAD case reports
Published: March 20, 2026
Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.
Journal: Dermatology and therapy
Published: November 14, 2025
Characterization and Management of Dupilumab-Associated Head and Neck Dermatitis-Experience of a Tertiary Center.
Journal: International journal of dermatology
Published: August 03, 2025
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: April 05, 2025
sQUIZ your knowledge! Ulcers on the red ink of tattoos.
Journal: European journal of dermatology : EJD
Published: March 20, 2025
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.
Journal: Dermatology and therapy
Published: December 10, 2024
The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal.
Journal: Dermatology and therapy
Published: December 05, 2024
Dupilumab-Associated Unmasking of Allergic Contact Dermatitis.
Journal: Contact dermatitis
Published: October 21, 2024
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 22, 2024
Last Updated: 09/26/2026